肿瘤学中的个性化医疗：医疗服务提供中的伦理问题

Personalized medicine in oncology: ethical implications for the delivery of healthcare.

作者信息

Egalite Nathalie, Groisman Iris Jaitovich, Godard Beatrice

机构信息

Omics-Ethics Research Group, Department of Preventive & Social Medicine, Public Health School, University of Montreal, C.P. 6128, succ. Centre-ville, Montreal, QC, H3C 3J7, Canada.

出版信息

Per Med. 2014 Sep;11(7):659-668. doi: 10.2217/pme.14.53.

DOI:10.2217/pme.14.53

PMID:29764052

Abstract

While personalized medicine brings benefits for the treatment of cancer, there are still key ethical issues at stake in developing personalized medicine in oncology. We propose an ethical analysis of personalized medicine in oncology that highlights the particularities of cancer care, critically assesses the scientific advances behind personalized medicine in oncology and emphasizes fairness in resource allocation in the delivery of personalized healthcare. This allows for a broader understanding of the real impacts on both recipients and the healthcare system.

摘要

虽然个性化医疗为癌症治疗带来了益处，但在肿瘤学领域发展个性化医疗仍存在关键的伦理问题。我们提出了对肿瘤学中个性化医疗的伦理分析，该分析突出了癌症护理的特殊性，批判性地评估了肿瘤学中个性化医疗背后的科学进展，并强调了在提供个性化医疗服务时资源分配的公平性。这有助于更广泛地理解其对接受者和医疗系统的实际影响。